Literature DB >> 791436

Endotoxin, bile salts and renal function in obstructive jaundice.

M E Bailey.   

Abstract

It is generally agreed that there is an increased incidence of postoperative renal failure in patients with obstructive jaundice. The proposition that this may be due to endotoxin, and that the endotoxin may be absorbed from the patient's own bowel flora, has been investigated. The study was conducted in patients and in animals. Twenty-four patients with obstructive jaundice were studied. Sixteen had endotoxin in the portal blood at operation and 13 of these had peripheral endotoxaemia at the time of operation or developed it during the 72 hours following operation. Only 3 of the patients had a proved possible site of infective origin for the endotoxaemia, the remainder absorbing the endotoxin from their own gastro-intestinal organisms. Portal endotoxaemia occurred when the serum bilirubin was 8-5 mg/100 ml or greater. There was a highly significant decrease in mean endogenous creatinine clearance postoperatively in patients with endotoxaemia, and expression of this as a percentage postoperative fall compared with preoperative levels enhanced the significance. Jaundiced patients without endotoxaemia had no significant fall in endogenous creatinine clearance. Matched non-jaundiced control patients did not develop portal or peripheral endotoxaemia, and there was no significant fall in postoperative creatinine clearance. Experiments using animals showed that the absence of bile salts in the intestinal tract in obstructive jaundice allows endotoxin to be absorbed, and that this absorption can be prevented by the oral administration of bile salts. The therapeutic implications in patients are discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 791436     DOI: 10.1002/bjs.1800631011

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  51 in total

1.  Hyperbaric oxygen prevents bacterial translocation in rats with obstructive jaundice.

Authors:  M L Akin; C Erenoglu; A Dal; A Erdemoglu; E Elbuken; A Batkin
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

2.  Impaired response of gastric vessels to prostaglandin E2 in rats with persistent obstructive jaundice.

Authors:  Y Nagahata; Y Azumi; H Moritomo; N Numata; N Kawakita; M Yano; H Onoyama; M Yamamoto
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

3.  Impaired nonspecific cellular immunity in experimental cholestasis.

Authors:  P T Roughneen; D B Drath; A D Kulkarni; B J Rowlands
Journal:  Ann Surg       Date:  1987-11       Impact factor: 12.969

4.  Factors affecting morbidity and mortality in biliary tract surgery.

Authors:  C H Su; F K P'eng; W Y Lui
Journal:  World J Surg       Date:  1992 May-Jun       Impact factor: 3.352

5.  Intestinal failure in obstructive jaundice.

Authors:  Stelios F Assimakopoulos; Constantine E Vagianos; Aristides Charonis; Vassiliki N Nikolopoulou; Chrisoula D Scopa
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

Review 6.  Pathophysiology of increased intestinal permeability in obstructive jaundice.

Authors:  Stelios F Assimakopoulos; Chrisoula D Scopa; Constantine E Vagianos
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

Review 7.  Current management of pancreatic carcinoma.

Authors:  K D Lillemoe
Journal:  Ann Surg       Date:  1995-02       Impact factor: 12.969

8.  Protective effect of the intravenous administration of ursodeoxycholic acid against endotoxemia in rats with obstructive jaundice.

Authors:  Y Hori; H Ohyanagi
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

9.  Altered serum transforming growth factor-beta1 and monocyte chemoattractant protein-1 levels in obstructive jaundice.

Authors:  Shyr-Ming Sheen-Chen; Hock-Liew Eng; Kuo-Sheng Hung
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

10.  Single stranded DNA binding antibodies in patients with obstructive jaundice.

Authors:  G Ohshio; F Furukawa; T Manabe; T Tobe; Y Hamashima
Journal:  Jpn J Surg       Date:  1985-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.